316 related articles for article (PubMed ID: 33194646)
1. Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era.
Carta R; Del Baldo G; Miele E; Po A; Besharat ZM; Nazio F; Colafati GS; Piccirilli E; Agolini E; Rinelli M; Lodi M; Cacchione A; Carai A; Boccuto L; Ferretti E; Locatelli F; Mastronuzzi A
Front Oncol; 2020; 10():566822. PubMed ID: 33194646
[TBL] [Abstract][Full Text] [Related]
2. Case report: Therapy-related myeloid neoplasms in three pediatric cases with medulloblastoma.
Mak LS; Li X; Chan WYK; Leung AWK; Cheuk DKL; Yuen LYP; So JCC; Ha SY; Liu APY
Front Oncol; 2024; 14():1364199. PubMed ID: 38595820
[TBL] [Abstract][Full Text] [Related]
3. The therapy of infantile malignant brain tumors: current status?
Kalifa C; Grill J
J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
[TBL] [Abstract][Full Text] [Related]
4. Sarcomas Associated With Genetic Cancer Predisposition Syndromes: A Review.
Farid M; Ngeow J
Oncologist; 2016 Aug; 21(8):1002-13. PubMed ID: 27401891
[TBL] [Abstract][Full Text] [Related]
5. Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review.
Taylor MD; Mainprize TG; Rutka JT
Neurosurgery; 2000 Oct; 47(4):888-901. PubMed ID: 11014429
[TBL] [Abstract][Full Text] [Related]
6. Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee.
Grant CN; Rhee D; Tracy ET; Aldrink JH; Baertschiger RM; Lautz TB; Glick RD; Rodeberg DA; Ehrlich PF; Christison-Lagay E
J Pediatr Surg; 2022 Mar; 57(3):430-442. PubMed ID: 34503817
[TBL] [Abstract][Full Text] [Related]
7. Brain tumors and syndromes in children.
Bleeker FE; Hopman SM; Merks JH; Aalfs CM; Hennekam RC
Neuropediatrics; 2014 Jun; 45(3):137-61. PubMed ID: 24535705
[TBL] [Abstract][Full Text] [Related]
8. Genitourinary manifestations of hereditary cancer predisposition syndromes in children.
Gillespie NJ; Van Mater D
Transl Androl Urol; 2020 Oct; 9(5):2331-2347. PubMed ID: 33209707
[TBL] [Abstract][Full Text] [Related]
9. Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.
Mitchell SG; Pencheva B; Porter CC
Curr Oncol Rep; 2019 Aug; 21(10):85. PubMed ID: 31414239
[TBL] [Abstract][Full Text] [Related]
10. Genetic syndromes predisposing to pediatric brain tumors.
Farouk Sait S; Walsh MF; Karajannis MA
Neurooncol Pract; 2021 Aug; 8(4):375-390. PubMed ID: 34277017
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
[TBL] [Abstract][Full Text] [Related]
12. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
[TBL] [Abstract][Full Text] [Related]
13. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
[TBL] [Abstract][Full Text] [Related]
14. Genetic Causes of Rare Pediatric Ovarian Tumors.
Plevová P; Geržová H
Klin Onkol; 2019; 32(Supplementum2):79-91. PubMed ID: 31409083
[TBL] [Abstract][Full Text] [Related]
15. Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.
Zou H; Poore B; Broniscer A; Pollack IF; Hu B
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32164294
[TBL] [Abstract][Full Text] [Related]
16. Inherited cancer syndromes in children and young adults.
D'Orazio JA
J Pediatr Hematol Oncol; 2010 Apr; 32(3):195-228. PubMed ID: 20186103
[TBL] [Abstract][Full Text] [Related]
17. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
[TBL] [Abstract][Full Text] [Related]
18. MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.
Colafati GS; Voicu IP; Carducci C; Miele E; Carai A; Di Loreto S; Marrazzo A; Cacchione A; Cecinati V; Tornesello A; Mastronuzzi A
Ther Adv Neurol Disord; 2018; 11():1756286418775375. PubMed ID: 29977341
[TBL] [Abstract][Full Text] [Related]
19. Update on pediatric cancer predisposition syndromes.
Schiffman JD; Geller JI; Mundt E; Means A; Means L; Means V
Pediatr Blood Cancer; 2013 Aug; 60(8):1247-52. PubMed ID: 23625733
[TBL] [Abstract][Full Text] [Related]
20. Recognizing and Managing Children with a Pediatric Cancer Predisposition Syndrome: A Guide for the Pediatrician.
Coury SA; Schneider KA; Schienda J; Tan WH
Pediatr Ann; 2018 May; 47(5):e204-e216. PubMed ID: 29750288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
